− FRUZAQLA (fruquintinib) is the First Novel Targeted Therapy in Japan for Metastatic Colorectal Cancer (mCRC) Regardless of Biomarker Status in Over a Decade About FRUZAQLA (fruquintinib) FRUZAQLA is ...
9d
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Not intended for UK and US audiences JASCAYD® (nerandomilast) now approved by Japan’s MHLW for the treatment of adults with idiopathic pulmonary ...
As tourism to Japan surges, so too has the use of its world-class medical facilities for treatment and surgery. But not all ...
Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as well as complications following smallpox vaccination in ...
Add Yahoo as a preferred source to see more of our stories on Google. A Japanese scientist has developed a treatment targeting chronic kidney disease (CKD) in cats, potentially extending their ...
March 26 (UPI) --Japan accepted two Palestinians injured during the war in for medical treatment Wednesday. It is the first time since the current Gaza war started in 2023 that people injured there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results